eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | down syndrome |
| Comorbidity | C0023467|acute myeloid leukemia |
| Sentences | 4 |
| PubMedID- 21557456 | Background: the aim of the jcclsg aml 9805 down study was to evaluate the effect of continuous and high-dose cytarabine combined chemotherapy on the survival outcome of acute myeloid leukemia (aml) with down syndrome (ds). |
| PubMedID- 25587735 | Approximately 20%-30% of tam survivors are at risk of development of acute myeloid leukemia (myeloid leukemia associated with down syndrome, ml-ds). |
| PubMedID- 25231553 | Prognosis and management of acute myeloid leukemia in patients with down syndrome. |
| PubMedID- 24962331 | Background: most down syndrome children with acute myeloid leukemia (ds-aml) have an overall excellent prognosis, however, patients who suffer an induction failure or relapse, have an extremely poor prognosis. |
Page: 1